14
Oct

Common prostate cancer treatment linked to later dementia, researcher says

A new retrospective study of the health records of prostate cancer patients supports an association between androgen deprivation therapy and future risk of dementia.

A new retrospective study of patient medical records suggests that men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as prostate cancer patients whose testosterone levels are not tampered with.

The study, clinic by researchers at the Stanford University School of Medicine and the University of Pennsylvania Perelman School of Medicine, also demonstrates emerging techniques for extracting biomedical data from ordinary patient medical records.

Read Full Article Here >>